Product category:
Mass spectrometers
News Release from: Thermo Fisher Scientific (Mass Spectrometry) | Subject: Brims centre
Edited by the Laboratorytalk Editorial
Team on 21 May 2007
Biomarker initiative expanded to
clinical research
Thermo Fisher Scientifics's Biomarker Research Initiative in Mass Spectrometry (Brims) centre has expanded its capabilities to involve clinical validation and clinical application assays
The centre was initially established to focus on protein biomarker discovery, and subsequently developed an end-to-end mass spectrometry workflow including a complete sample preparation protocol as well as Sieve, a new software tool which automates label-free, semi-quantitative differential expression of proteins and peptides by comparing LC/MS analyses from large datasets Thermo Fisher Scientific originally partnered with Massachusetts General Hospital on Brims to focus on protein biomarker discovery
This article was originally published on Laboratorytalk on 17 Sep 2008 at 8.00am (UK)
Related stories
TFS Proteome Discoverer powered by IVM
Inforsense has announced that Thermo Fisher Scientific has begun shipping its Proteome Discoverer software with integrated protein annotation, powered by the Inforsense Virtual Machine (IVM).
TFS and Sage-N launch Sorcerer proteomics platform
Thermo Fisher Scientific and Sage-N Research have released a proteomics software platform designed specifically for the Enterprise Linux market.
The large quantity of well-annotated plasma samples that were available at the hospital were ideally suited for research in biomarker discovery using the Thermo Scientific LTQ FT and LTQ Orbitrap.
Moving into the next stage of biomarker verification, the center now uses the Thermo Scientific TSQ Quantum triple-quadrupole platform to develop targeted highly selective reaction monitoring (H-SRM) and multiple reaction monitoring assays for peptides and protein biomarker quantitation.
Mary Lopez, director of the Brims centre comments: "The centre's focus is shifting.
"Proteomics is evolving and as proteomics has gone from a science that was really more discovery based into a science that is becoming now more quantitative and has applications in the clinical world, we have also moved forward.
"The Brims center will continue to expand and establish collaborations with the leading scientists in biomarker research in cancer and cardiovascular disease, with the aim of developing clinical workflows and platforms.
Following the Thermo Fisher acquisition of Cohesive Technologies, Brims incorporates the novel Thermo Scientific TurboFlow technology system's novel approach to sample preparation and separation for MS.
The TurboFlow technology minimises sample preparation, especially for drug discovery, drug development and clinical research applications resulting in a unique LC-MS/MS solution when coupled with the TSQ Quantum triple quadrupole mass spectrometer and Faims (high-field asymmetric ion mobility mass spectrometry) technology.
The Brims center also utilises Thermo Fisher protein/peptide sample enrichment products, as well as the Silac protein quantitation kits which, when used in conjunction with Thermo Scientific high resolution mass spectrometers, help facilitate MS analysis of low-abundance proteins.
• Thermo Fisher Scientific (Mass Spectrometry): contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
